Elevance Health, Inc. (ELV)

Elevance Health Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for Elevance Health stock ranges from a low of $297 to a high of $485. The average analyst price target of $392.47 forecasts a 18.66% increase in the stock price over the next year.

Price Target: $392.47 (+18.66%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$297	$392.47	$398	$485
Change	-10.20%	+18.66%	+20.33%	+46.64%

Analyst Ratings

The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	5	4	4	4	4	4
Buy	7	8	8	8	6	6
Hold	2	3	3	3	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	15	15	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Langston TD Cowen	TD Cowen	Strong Buy Maintains $380 → $400	Strong Buy	Maintains	$380 → $400	+20.94%	Nov 26, 2025
Ann Hynes Mizuho	Mizuho	Buy Maintains $420 → $400	Buy	Maintains	$420 → $400	+20.94%	Nov 4, 2025
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $384 → $394	Buy	Maintains	$384 → $394	+19.12%	Oct 28, 2025
Ryan Langston TD Cowen	TD Cowen	Strong Buy Maintains $330 → $380	Strong Buy	Maintains	$330 → $380	+14.89%	Oct 23, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $412 → $403	Buy	Maintains	$412 → $403	+21.84%	Oct 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

200.09B

Increased by 13.17%

from 176.81B

Revenue Next Year

207.42B

Increased by 3.66%

from 200.09B

EPS This Year

30.29

Increased by 17.94%

from 25.68

EPS Next Year

27.66

Decreased by -8.67%

from 30.29

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	121.87B	138.64B	156.60B	171.34B	176.81B	200.09B	207.42B
Revenue Growth	16.94%	13.77%	12.95%	9.41%	3.19%	13.17%	3.66%
EPS	17.98	24.95	24.28	25.22	25.68	30.29	27.66
EPS Growth	-2.65%	38.77%	-2.69%	3.87%	1.82%	17.94%	-8.67%
Forward PE	-	-	-	-	-	10.92	11.96
No. Analysts	-	-	-	-	-	25	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	211.1B	228.8B
Avg	200.1B	207.4B
Low	192.7B	193.6B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	19.4%	14.3%
Avg	13.2%	3.7%
Low	9.0%	-3.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	31.68	33.17
Avg	30.29	27.66
Low	29.08	24.01

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	23.4%	9.5%
Avg	17.9%	-8.7%
Low	13.2%	-20.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.